@article{f750e638ec5d4ca0b73333b2cd0c4ebb,
title = "Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial",
keywords = "DOSE-DENSE CHEMOTHERAPY, PHASE-III TRIAL, NEOADJUVANT CHEMOTHERAPY, CYCLOPHOSPHAMIDE, DOCETAXEL, EPIRUBICIN, THERAPY, METAANALYSIS, ENHANCEMENT, COMBINATION, 3122 Cancers",
author = "Heikki Joensuu and Pirkko-Liisa Kellokumpu-Lehtinen and Riikka Huovinen and Arja Jukkola and Minna Tanner and Johan Ahlgren and Paivi Auvinen and Outi Lahdenper{\"a} and Kenneth Villman and Paul Nyandoto and Greger Nilsson and Paula Poikonen-Saksela and Vesa Kataja and Petri Bono and Jouni Junnila and Henrik Lindman",
year = "2022",
month = apr,
day = "1",
doi = "10.1200/JCO.21.02054",
language = "English",
volume = "40",
pages = "1051--+",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "Lippincott Williams and Wilkins",
number = "10",
}